In gastric cancer cells, METTL3 stimulates the m6A modification of heparin binding growth factor (HDGF) mRNA, and IGF2BP3 then directly binds to the m6A-modified mRNA and enhanced RNA stability. The gene discussed is METTL3; the disease is gastric cancer.